Published March 14, 2024 | Version v1
Journal article Open

Antibody Characterization Report for Sphingosine 1-phosphate receptor 1 (S1PR1)

  • 1. ROR icon Montreal Neurological Institute and Hospital
  • 2. Advanced BioImaging Facility (ABIF)
  • 3. ROR icon McGill University
  • 4. The Neuro's Early Drug Discovery Unit (EDDU)

Description

A peer-reviewed antibody characterization article corresponding to this Zenodo preprint is openly available at F1000Research: https://doi.org/10.12688/f1000research.153244.3

This report presents a guide to selecting high-quality commercial antibodies against Sphingosine 1-phosphate receptor 1 (S1PR1) by Western blot and immunoprecipitation and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls.

Work presented in this study was supported in part by the Emory-Sage-SGC TREAT-AD center established by the National Institutes of Aging under the award number U54AG065187. 

Files

Sphingosine 1-phosphate receptor 1_S1PR1_YCharOS report_v3.pdf

Files (4.6 MB)

Additional details

Dates

Submitted
2024-03-14